Due to a labeling error, the Pharmacy and Poisons Board (PPB) has issued a recall for Flamodip 5mg tablets, manufactured by Medico Remedies. 

In a statement, the Board noted that the product's labeling does not accurately reflect its content. 

"The secondary packaging is labeled as Flamodip-5 (Amlodipine), while the first packaging is labeled as Flamodip-5 (Enalapril)," read the statement.

As a result, the PPB has warned the public against the use, sale, and distribution of the product.

Flamodip-5 (Amlodipine) is typically used alone or with other medications to treat high blood pressure in adults and children aged six years and older. 

It is also prescribed to manage certain types of angina (chest pain) and coronary artery disease, which involves the narrowing of blood vessels supplying blood to the heart.

On the other hand, Enalapril is used to treat high blood pressure and heart failure (the weakening of heart function). 

Amlodipine works by relaxing blood vessels, allowing blood to flow more easily, thereby reducing blood pressure while Enalapril relaxes and widens blood vessels, helping the heart pump blood more effectively, which in turn lowers elevated blood pressure.

However, the two contain different active ingredients: Amlodipine, a calcium channel blocker, and Enalapril, an angiotensin-converting enzyme (ACE) inhibitor.